| Mutations in the spliceosome machinery, a novel and ubiquitous pathway in leukemogenesis H Makishima, V Visconte, H Sakaguchi, AM Jankowska, S Abu Kar, ... Blood, The Journal of the American Society of Hematology 119 (14), 3203-3210, 2012 | 481 | 2012 |
| STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia A Jerez, MJ Clemente, H Makishima, H Koskela, F LeBlanc, K Peng Ng, ... Blood, The Journal of the American Society of Hematology 120 (15), 3048-3057, 2012 | 443 | 2012 |
| Discovery of somatic STAT5b mutations in large granular lymphocytic leukemia HLM Rajala, S Eldfors, H Kuusanmäki, AJ Van Adrichem, T Olson, ... Blood, The Journal of the American Society of Hematology 121 (22), 4541-4550, 2013 | 321 | 2013 |
| Somatic SETBP1 mutations in myeloid malignancies H Makishima, K Yoshida, N Nguyen, B Przychodzen, M Sanada, Y Okuno, ... Nature genetics 45 (8), 942-946, 2013 | 281 | 2013 |
| SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts V Visconte, H Makishima, A Jankowska, H Szpurka, F Traina, A Jerez, ... Leukemia 26 (3), 542-545, 2012 | 275 | 2012 |
| SF3B1 haploinsufficiency leads to formation of ring sideroblasts in myelodysplastic syndromes V Visconte, HJ Rogers, J Singh, J Barnard, M Bupathi, F Traina, ... Blood, The Journal of the American Society of Hematology 120 (16), 3173-3186, 2012 | 218 | 2012 |
| Targeting IRAK1 as a therapeutic approach for myelodysplastic syndrome GW Rhyasen, L Bolanos, J Fang, A Jerez, M Wunderlich, C Rigolino, ... Cancer cell 24 (1), 90-104, 2013 | 211 | 2013 |
| Patterns of missplicing due to somatic U2AF1 mutations in myeloid neoplasms B Przychodzen, A Jerez, K Guinta, MA Sekeres, R Padgett, ... Blood, The Journal of the American Society of Hematology 122 (6), 999-1006, 2013 | 205 | 2013 |
| STAT3 mutations indicate the presence of subclinical T-cell clones in a subset of aplastic anemia and myelodysplastic syndrome patients A Jerez, MJ Clemente, H Makishima, H Rajala, I Gómez-Seguí, T Olson, ... Blood, The Journal of the American Society of Hematology 122 (14), 2453-2459, 2013 | 169 | 2013 |
| Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes MA Sekeres, RV Tiu, R Komrokji, J Lancet, AS Advani, M Afable, ... Blood, The Journal of the American Society of Hematology 120 (25), 4945-4951, 2012 | 165 | 2012 |
| Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis A Jerez, Y Sugimoto, H Makishima, A Verma, AM Jankowska, ... Blood, The Journal of the American Society of Hematology 119 (25), 6109-6117, 2012 | 142 | 2012 |
| Topography, clinical, and genomic correlates of 5q myeloid malignancies revisited A Jerez, LP Gondek, AM Jankowska, H Makishima, B Przychodzen, ... Journal of clinical oncology 30 (12), 1343, 2012 | 134 | 2012 |
| Loss of Tifab, a del(5q) MDS gene, alters hematopoiesis through derepression of Toll-like receptor–TRAF6 signaling ME Varney, M Niederkorn, H Konno, T Matsumura, J Gohda, N Yoshida, ... Journal of Experimental Medicine 212 (11), 1967-1985, 2015 | 115 | 2015 |
| Response to lenalidomide in myelodysplastic syndromes with del (5q): influence of cytogenetics and mutations M Mallo, M Del Rey, M Ibanez, MJ Calasanz, L Arenillas, MJ Larráyoz, ... British journal of haematology 162 (1), 74-86, 2013 | 115 | 2013 |
| The analysis of clonal diversity and therapy responses using STAT3 mutations as a molecular marker in large granular lymphocytic leukemia HLM Rajala, T Olson, MJ Clemente, S Lagström, P Ellonen, T Lundan, ... haematologica 100 (1), 91, 2015 | 105 | 2015 |
| Fermi-and non-Fermi-liquid behavior in the anisotropic multichannel Kondo model: Bethe Ansatz solution N Andrei, A Jerez Physical review letters 74 (22), 4507, 1995 | 104 | 1995 |
| Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis J Broseus, L Florensa, E Zipperer, S Schnittger, L Malcovati, ... Haematologica 97 (7), 1036, 2012 | 96 | 2012 |
| Clinical features and treatment outcomes in large granular lymphocytic leukemia (LGLL) SR Sanikommu, MJ Clemente, P Chomczynski, MG Afable, A Jerez, ... Leukemia & lymphoma 59 (2), 416-422, 2018 | 95 | 2018 |
| Spliceosomal gene mutations are frequent events in the diverse mutational spectrum of chronic myelomonocytic leukemia but largely absent in juvenile myelomonocytic leukemia SA Kar, A Jankowska, H Makishima, V Visconte, A Jerez, Y Sugimoto, ... Haematologica 98 (1), 107, 2013 | 89 | 2013 |
| Deep sequencing of the T-cell receptor repertoire in CD8+ T-large granular lymphocyte leukemia identifies signature landscapes MJ Clemente, B Przychodzen, A Jerez, BE Dienes, MG Afable, ... Blood, The Journal of the American Society of Hematology 122 (25), 4077-4085, 2013 | 86 | 2013 |
